APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gene Sequencing

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Gene Sequencing Market Outlook and Growth Opportunities 2026

22 December 2025195 pages

Choose your research edition.

Industry ResearchGene Sequencing Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Gene Sequencing Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Gene Sequencing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gene Sequencing Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Gene Sequencing Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Gene Sequencing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Gene Sequencing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Gene Sequencing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gene Sequencing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Gene Sequencing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Gene Sequencing market include Illumina, Thermo Fisher Scientific, Eurofins Scientific, BGI Genomics, Natera, Berry Genomics, Roche, Novogene and Mgi Tech, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Gene Sequencing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Gene Sequencing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Gene Sequencing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Gene Sequencing market.

Gene Sequencing Segment by Company

Illumina

Thermo Fisher Scientific

Eurofins Scientific

BGI Genomics

Natera

Berry Genomics

Roche

Novogene

Mgi Tech

LabCorp

Pacific Biosciences

Azenta Life Sciences

Oxford Nanopore

Macrogen

Gene Sequencing Segment by Type

Next-generation Sequencing

Third and Fourth Generation Sequencing

First-generation Sequencing

Gene Sequencing Segment by Application

Academic Research

Clinical Research

Hospital Clinic

Pharmaceuticals and Biotechnology

Others

Gene Sequencing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Gene Sequencing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Gene Sequencing key companies, revenue, market share, and recent developments.

3. To split the Gene Sequencing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Gene Sequencing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Gene Sequencing significant trends, drivers, influence factors in global and regions.

6. To analyze Gene Sequencing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Sequencing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gene Sequencing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Sequencing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gene Sequencing industry.

Chapter 3: Detailed analysis of Gene Sequencing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Gene Sequencing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Gene Sequencing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Gene Sequencing Industry Trends Table 2. Gene Sequencing Industry Drivers Table 3. Gene Sequencing Industry Opportunities and Challenges Table 4. Gene Sequencing Industry Restraints Table 5. Global Gene Sequencing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Gene Sequencing Revenue Share by Company (2021-2026) Table 7. Global Gene Sequencing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Gene Sequencing Key Company Manufacturing Base & Headquarters Table 9. Global Gene Sequencing Company, Product Type & Application Table 10. Global Gene Sequencing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Gene Sequencing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Next-generation Sequencing Table 15. Significant Companies of Third and Fourth Generation Sequencing Table 16. Significant Companies of First-generation Sequencing Table 17. Global Gene Sequencing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Gene Sequencing Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Gene Sequencing Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Gene Sequencing Sales Value Share by Type (2021-2026) Table 21. Global Gene Sequencing Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Academic Research Table 23. Significant Companies of Clinical Research Table 24. Significant Companies of Hospital Clinic Table 25. Significant Companies of Pharmaceuticals and Biotechnology Table 26. Significant Companies of Others Table 27. Global Gene Sequencing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Gene Sequencing Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Gene Sequencing Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Gene Sequencing Sales Value Share by Application (2021-2026) Table 31. Global Gene Sequencing Sales Value Share by Application (2027-2032) Table 32. Global Gene Sequencing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Gene Sequencing Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Gene Sequencing Sales Value Share by Region (2021-2026) Table 35. Global Gene Sequencing Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Gene Sequencing Sales Value Share by Region (2027-2032) Table 37. Global Gene Sequencing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Gene Sequencing Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Gene Sequencing Sales Value Market Share by Country (2021-2026) Table 40. Global Gene Sequencing Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Gene Sequencing Sales Value Market Share by Country (2027-2032) Table 42. Illumina Company Information Table 43. Illumina Business Overview Table 44. Illumina Gene Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Illumina Gene Sequencing Product Portfolio Table 46. Illumina Recent Development Table 47. Thermo Fisher Scientific Company Information Table 48. Thermo Fisher Scientific Business Overview Table 49. Thermo Fisher Scientific Gene Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Thermo Fisher Scientific Gene Sequencing Product Portfolio Table 51. Thermo Fisher Scientific Recent Development Table 52. Eurofins Scientific Company Information Table 53. Eurofins Scientific Business Overview Table 54. Eurofins Scientific Gene Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Eurofins Scientific Gene Sequencing Product Portfolio Table 56. Eurofins Scientific Recent Development Table 57. BGI Genomics Company Information Table 58. BGI Genomics Business Overview Table 59. BGI Genomics Gene Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. BGI Genomics Gene Sequencing Product Portfolio Table 61. BGI Genomics Recent Development Table 62. Natera Company Information Table 63. Natera Business Overview Table 64. Natera Gene Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Natera Gene Sequencing Product Portfolio Table 66. Natera Recent Development Table 67. Berry Genomics Company Information Table 68. Berry Genomics Business Overview Table 69. Berry Genomics Gene Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Berry Genomics Gene Sequencing Product Portfolio Table 71. Berry Genomics Recent Development Table 72. Roche Company Information Table 73. Roche Business Overview Table 74. Roche Gene Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Roche Gene Sequencing Product Portfolio Table 76. Roche Recent Development Table 77. Novogene Company Information Table 78. Novogene Business Overview Table 79. Novogene Gene Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Novogene Gene Sequencing Product Portfolio Table 81. Novogene Recent Development Table 82. Mgi Tech Company Information Table 83. Mgi Tech Business Overview Table 84. Mgi Tech Gene Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Mgi Tech Gene Sequencing Product Portfolio Table 86. Mgi Tech Recent Development Table 87. LabCorp Company Information Table 88. LabCorp Business Overview Table 89. LabCorp Gene Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. LabCorp Gene Sequencing Product Portfolio Table 91. LabCorp Recent Development Table 92. Pacific Biosciences Company Information Table 93. Pacific Biosciences Business Overview Table 94. Pacific Biosciences Gene Sequencing Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Pacific Biosciences Gene Sequencing Product Portfolio Table 96. Pacific Biosciences Recent Development Table 97. Azenta Life Sciences Company Information Table 98. Azenta Life Sciences Business Overview Table 99. Azenta Life Sciences Gene Sequencing Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Azenta Life Sciences Gene Sequencing Product Portfolio Table 101. Azenta Life Sciences Recent Development Table 102. Oxford Nanopore Company Information Table 103. Oxford Nanopore Business Overview Table 104. Oxford Nanopore Gene Sequencing Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Oxford Nanopore Gene Sequencing Product Portfolio Table 106. Oxford Nanopore Recent Development Table 107. Macrogen Company Information Table 108. Macrogen Business Overview Table 109. Macrogen Gene Sequencing Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Macrogen Gene Sequencing Product Portfolio Table 111. Macrogen Recent Development Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Gene Sequencing Product Image Figure 2. Global Gene Sequencing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gene Sequencing Market Size (2021-2032) & (US$ Million) Figure 4. Global Gene Sequencing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Next-generation Sequencing Image Figure 8. Third and Fourth Generation Sequencing Image Figure 9. First-generation Sequencing Image Figure 10. Global Gene Sequencing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Gene Sequencing Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Gene Sequencing Sales Value Share by Type (2021-2032) Figure 13. Academic Research Image Figure 14. Clinical Research Image Figure 15. Hospital Clinic Image Figure 16. Pharmaceuticals and Biotechnology Image Figure 17. Others Image Figure 18. Global Gene Sequencing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Gene Sequencing Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Gene Sequencing Sales Value Share by Application (2021-2032) Figure 21. Global Gene Sequencing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Gene Sequencing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Gene Sequencing Sales Value (2021-2032) & (US$ Million) Figure 24. North America Gene Sequencing Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Gene Sequencing Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Gene Sequencing Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Gene Sequencing Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Gene Sequencing Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Gene Sequencing Sales Value (2021-2032) & (US$ Million) Figure 30. South America Gene Sequencing Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Gene Sequencing Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Gene Sequencing Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Gene Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Gene Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Gene Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Gene Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Gene Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Gene Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Gene Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Gene Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Gene Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Gene Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Gene Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Gene Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Gene Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Gene Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Gene Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Gene Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Gene Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Gene Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Gene Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Gene Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Gene Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Gene Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Gene Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Gene Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Gene Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Gene Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Gene Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Gene Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Gene Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Gene Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Gene Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Gene Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Gene Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Gene Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Gene Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Gene Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Gene Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Gene Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Gene Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Gene Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Gene Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Gene Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Gene Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Gene Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Gene Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Gene Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Gene Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Gene Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Gene Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Gene Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Gene Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Gene Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Gene Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Gene Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Gene Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Gene Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Gene Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Gene Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Gene Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Gene Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Gene Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Gene Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Gene Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Gene Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Gene Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Gene Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Gene Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Gene Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Gene Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Gene Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Gene Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Gene Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Gene Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Gene Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Gene Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Gene Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Gene Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Gene Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Gene Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Gene Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Gene Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Gene Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Gene Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Gene Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Next-generation Sequencing
  • Third and Fourth Generation Sequencing
  • First-generation Sequencing
Applications
  • Academic Research
  • Clinical Research
  • Hospital Clinic
  • Pharmaceuticals and Biotechnology
  • Others
Companies covered
  • Illumina
  • Thermo Fisher Scientific
  • Eurofins Scientific
  • BGI Genomics
  • Natera
  • Berry Genomics
  • Roche
  • Novogene
  • Mgi Tech
  • LabCorp
  • Pacific Biosciences
  • Azenta Life Sciences
  • Oxford Nanopore
  • Macrogen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Gene Sequencing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Gene Sequencing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Gene Sequencing Market Dynamics
  1. 2.1 Gene Sequencing Industry Trends
  2. 2.2 Gene Sequencing Industry Drivers
  3. 2.3 Gene Sequencing Industry Opportunities and Challenges
  4. 2.4 Gene Sequencing Industry Restraints
3 Gene Sequencing Market by Company
  1. 3.1 Global Gene Sequencing Company Revenue Ranking in 2025
  2. 3.2 Global Gene Sequencing Revenue by Company (2021-2026)
  3. 3.3 Global Gene Sequencing Company Ranking (2024-2026)
  4. 3.4 Global Gene Sequencing Company Manufacturing Base and Headquarters
  5. 3.5 Global Gene Sequencing Company Product Type and Application
  6. 3.6 Global Gene Sequencing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Gene Sequencing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Gene Sequencing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Gene Sequencing Market by Type
  1. 4.1 Gene Sequencing Type Introduction
  2. 4.1.1 Next-generation Sequencing
  3. 4.1.2 Third and Fourth Generation Sequencing
  4. 4.1.3 First-generation Sequencing
  5. 4.2 Global Gene Sequencing Sales Value by Type
  6. 4.2.1 Global Gene Sequencing Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Gene Sequencing Sales Value by Type (2021-2032)
  8. 4.2.3 Global Gene Sequencing Sales Value Share by Type (2021-2032)
5 Gene Sequencing Market by Application
  1. 5.1 Gene Sequencing Application Introduction
  2. 5.1.1 Academic Research
  3. 5.1.2 Clinical Research
  4. 5.1.3 Hospital Clinic
  5. 5.1.4 Pharmaceuticals and Biotechnology
  6. 5.1.5 Others
  7. 5.2 Global Gene Sequencing Sales Value by Application
  8. 5.2.1 Global Gene Sequencing Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Gene Sequencing Sales Value by Application (2021-2032)
  10. 5.2.3 Global Gene Sequencing Sales Value Share by Application (2021-2032)
6 Gene Sequencing Regional Value Analysis
  1. 6.1 Global Gene Sequencing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Gene Sequencing Sales Value by Region (2021-2032)
  3. 6.2.1 Global Gene Sequencing Sales Value by Region: 2021-2026
  4. 6.2.2 Global Gene Sequencing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Gene Sequencing Sales Value (2021-2032)
  7. 6.3.2 North America Gene Sequencing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Gene Sequencing Sales Value (2021-2032)
  10. 6.4.2 Europe Gene Sequencing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Gene Sequencing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Gene Sequencing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Gene Sequencing Sales Value (2021-2032)
  16. 6.6.2 South America Gene Sequencing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Gene Sequencing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Gene Sequencing Sales Value Share by Country, 2025 VS 2032
7 Gene Sequencing Country-level Value Analysis
  1. 7.1 Global Gene Sequencing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Gene Sequencing Sales Value by Country (2021-2032)
  3. 7.2.1 Global Gene Sequencing Sales Value by Country (2021-2026)
  4. 7.2.2 Global Gene Sequencing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Gene Sequencing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Gene Sequencing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Gene Sequencing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Gene Sequencing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Gene Sequencing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Gene Sequencing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Gene Sequencing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Gene Sequencing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Gene Sequencing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Gene Sequencing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Gene Sequencing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Gene Sequencing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Gene Sequencing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Gene Sequencing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Gene Sequencing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Gene Sequencing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Gene Sequencing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Gene Sequencing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Gene Sequencing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Gene Sequencing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Gene Sequencing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Gene Sequencing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Gene Sequencing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Gene Sequencing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Gene Sequencing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Gene Sequencing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Gene Sequencing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Gene Sequencing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Gene Sequencing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Gene Sequencing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Gene Sequencing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Gene Sequencing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Gene Sequencing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Gene Sequencing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Gene Sequencing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Gene Sequencing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Gene Sequencing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Gene Sequencing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Gene Sequencing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Gene Sequencing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Gene Sequencing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Gene Sequencing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Gene Sequencing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Gene Sequencing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Gene Sequencing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Gene Sequencing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Gene Sequencing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Gene Sequencing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Gene Sequencing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Gene Sequencing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Gene Sequencing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Gene Sequencing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Gene Sequencing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Gene Sequencing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Gene Sequencing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Gene Sequencing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Gene Sequencing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Gene Sequencing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Gene Sequencing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Gene Sequencing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Gene Sequencing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Gene Sequencing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Gene Sequencing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Gene Sequencing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Gene Sequencing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Gene Sequencing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Gene Sequencing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Gene Sequencing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Gene Sequencing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Gene Sequencing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Gene Sequencing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Gene Sequencing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Gene Sequencing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Gene Sequencing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Gene Sequencing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Gene Sequencing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Gene Sequencing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Gene Sequencing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Gene Sequencing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Gene Sequencing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Gene Sequencing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Gene Sequencing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Gene Sequencing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Gene Sequencing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Illumina
  2. 8.1.1 Illumina Company Information
  3. 8.1.2 Illumina Business Overview
  4. 8.1.3 Illumina Gene Sequencing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Illumina Gene Sequencing Product Portfolio
  6. 8.1.5 Illumina Recent Developments
  7. 8.2 Thermo Fisher Scientific
  8. 8.2.1 Thermo Fisher Scientific Company Information
  9. 8.2.2 Thermo Fisher Scientific Business Overview
  10. 8.2.3 Thermo Fisher Scientific Gene Sequencing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Thermo Fisher Scientific Gene Sequencing Product Portfolio
  12. 8.2.5 Thermo Fisher Scientific Recent Developments
  13. 8.3 Eurofins Scientific
  14. 8.3.1 Eurofins Scientific Company Information
  15. 8.3.2 Eurofins Scientific Business Overview
  16. 8.3.3 Eurofins Scientific Gene Sequencing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Eurofins Scientific Gene Sequencing Product Portfolio
  18. 8.3.5 Eurofins Scientific Recent Developments
  19. 8.4 BGI Genomics
  20. 8.4.1 BGI Genomics Company Information
  21. 8.4.2 BGI Genomics Business Overview
  22. 8.4.3 BGI Genomics Gene Sequencing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 BGI Genomics Gene Sequencing Product Portfolio
  24. 8.4.5 BGI Genomics Recent Developments
  25. 8.5 Natera
  26. 8.5.1 Natera Company Information
  27. 8.5.2 Natera Business Overview
  28. 8.5.3 Natera Gene Sequencing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Natera Gene Sequencing Product Portfolio
  30. 8.5.5 Natera Recent Developments
  31. 8.6 Berry Genomics
  32. 8.6.1 Berry Genomics Company Information
  33. 8.6.2 Berry Genomics Business Overview
  34. 8.6.3 Berry Genomics Gene Sequencing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Berry Genomics Gene Sequencing Product Portfolio
  36. 8.6.5 Berry Genomics Recent Developments
  37. 8.7 Roche
  38. 8.7.1 Roche Company Information
  39. 8.7.2 Roche Business Overview
  40. 8.7.3 Roche Gene Sequencing Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Roche Gene Sequencing Product Portfolio
  42. 8.7.5 Roche Recent Developments
  43. 8.8 Novogene
  44. 8.8.1 Novogene Company Information
  45. 8.8.2 Novogene Business Overview
  46. 8.8.3 Novogene Gene Sequencing Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Novogene Gene Sequencing Product Portfolio
  48. 8.8.5 Novogene Recent Developments
  49. 8.9 Mgi Tech
  50. 8.9.1 Mgi Tech Company Information
  51. 8.9.2 Mgi Tech Business Overview
  52. 8.9.3 Mgi Tech Gene Sequencing Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Mgi Tech Gene Sequencing Product Portfolio
  54. 8.9.5 Mgi Tech Recent Developments
  55. 8.10 LabCorp
  56. 8.10.1 LabCorp Company Information
  57. 8.10.2 LabCorp Business Overview
  58. 8.10.3 LabCorp Gene Sequencing Revenue and Gross Margin (2021-2026)
  59. 8.10.4 LabCorp Gene Sequencing Product Portfolio
  60. 8.10.5 LabCorp Recent Developments
  61. 8.11 Pacific Biosciences
  62. 8.11.1 Pacific Biosciences Company Information
  63. 8.11.2 Pacific Biosciences Business Overview
  64. 8.11.3 Pacific Biosciences Gene Sequencing Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Pacific Biosciences Gene Sequencing Product Portfolio
  66. 8.11.5 Pacific Biosciences Recent Developments
  67. 8.12 Azenta Life Sciences
  68. 8.12.1 Azenta Life Sciences Company Information
  69. 8.12.2 Azenta Life Sciences Business Overview
  70. 8.12.3 Azenta Life Sciences Gene Sequencing Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Azenta Life Sciences Gene Sequencing Product Portfolio
  72. 8.12.5 Azenta Life Sciences Recent Developments
  73. 8.13 Oxford Nanopore
  74. 8.13.1 Oxford Nanopore Company Information
  75. 8.13.2 Oxford Nanopore Business Overview
  76. 8.13.3 Oxford Nanopore Gene Sequencing Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Oxford Nanopore Gene Sequencing Product Portfolio
  78. 8.13.5 Oxford Nanopore Recent Developments
  79. 8.14 Macrogen
  80. 8.14.1 Macrogen Company Information
  81. 8.14.2 Macrogen Business Overview
  82. 8.14.3 Macrogen Gene Sequencing Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Macrogen Gene Sequencing Product Portfolio
  84. 8.14.5 Macrogen Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst